関連する実験動画
Updated: Jul 5, 2026

12:03
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
急性心膜炎の予後不良を示す指標
Massimo Imazio1, Enrico Cecchi, Brunella Demichelis
1Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, 10141 Torino, Italy. massimo_imazio@yahoo.it
Circulation
|May 16, 2007
まとめ
発熱,亜急性経過,大出血,急性 perikarditis の治療失敗などの臨床的特徴は,特定の原因と合併症を示すことができます. これらの指標は,より良い結果のためにより密接なモニタリングと管理を必要とする患者を特定するのに役立ちます.
科学分野:
- 心臓病学 心臓病学
- 内科内科は,内科の内科である.
- クリニック・リサーチ 臨床研究
背景:
- 急性心膜炎の予後評価は,患者のトリアージに不可欠です.
- 特定の原因や合併症による高リスク患者の特定は,臨床管理に役立ちます.
研究 の 目的:
- 発現時の臨床的特徴と,急性心膜炎の特定の原因または合併症との関係を評価する.
主な方法:
- 急性心周炎 (心筋梗塞後の心筋梗塞を除く) の453人の成人の患者の見通し評価.
- 特定の原因と合併症の危険因子を特定するための多変量分析.
- 結果を追跡するための平均フォローアップ期間は31ヶ月.
主要な成果:
- 特定の原因は,患者の16.8%で特定されました (自己免疫性,腫瘍性,結核性,性).
- 発熱>38°C,亜急性経過,大出血/タンポネード,NSAIDの失敗に関連する特定の原因のリスクの増加.
- 合併症 (再発,タンポネード,収縮) は21.0%で発生し,リスク要因には女性の性別,大量出血/タンポネード,およびNSAIDの失敗が含まれています.
結論:
- 発熱>38°C,亜急性発症,大出血/タンポネード,アスピリンやNSAIDに対する反応不良などの臨床指標は,より高いリスクを有する患者を特定するのに価値があります.
- これらの特徴は,急性心膜炎の患者に対する臨床的決定を導き,早期の介入と潜在的な合併症の管理を容易にする.
関連する概念動画
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

